Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
775.95
Change Change %
-0.20 -0.03%

Updated:19 Sep, 2018, 15:57 PM IST

BSE
775.70
Change Change %
-0.90 -0.12%

Updated:19 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
JP Morgan
N/A
20-07-2016 Buy 759.30 900.00
N/A
Closed Long (1Y)
20-07-2017

JP Morgan initiates Aurobindo Pharma with overweight

JP Morgan has initiated coverage on Aurobindo Pharma with a "overweight" rating. Expect 18 per cent CAGR in earnings over FY17-19. US is a key growth driver with improved execution. Debt reduction to be key trigger over next 2 years. Estimate margin expansion of 150 basis points by FY18.

Top